Wayne Myers, DO
Surgery · Washington, PANPI 1932413325
Payments from drug & device makers
Across 135 payments — averaging $111.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$14K
- Integra Lifesciences Corporation$450
- Innocoll Pharmaceuticals Limited$122
- Johnson & Johnson$94
- Smith+Nephew$84
- AstraZeneca$68
- plus $143 from 6 others
What the payments were for
- Travel & lodging$1,43710%
- Food & beverage$2,11214%
- Education$11,08874%
- Other$4053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 114 | $14,080 |
| Integra Lifesciences Corporation | 4 | $450 |
| Innocoll Pharmaceuticals Limited | 1 | $122 |
| Johnson & Johnson | 4 | $94 |
| Smith+Nephew | 4 | $84 |
| AstraZeneca | 1 | $68 |
| Organogenesis Inc. | 2 | $48 |
| Innovation Technologies Inc | 1 | $24 |
| CSL Behring | 1 | $20 |
| Davol Inc. | 1 | $19 |
| Covidien LP | 1 | $16 |
| Teleflex LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$12,422
- MICROMATRIX$245
- CYTAL$159
- XARACOLL$122
How this compares
$15,042 in reported general payments places this provider in the 90th percentile of 1,424 surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 13 | $14,314 |
| Pantoprazole Sodium | 29 | $247 |
| Oxycodone Hcl | 45 | $141 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $92 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $84 | $14,31413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,424 surgery providers in Pennsylvania.
Other surgery in Washington
- Giorgos KarakousisPhiladelphia$8.8M
- James MarkmannPhiladelphia$1.8M
- John MiuraPhiladelphia$1.3M
- Martin WijkstromPittsburgh$1.3M
- Andy KiserPittsburgh$1.1M
- Blair JobePittsburgh$827K
- Glenn SteeleDanville$698K
- Olwadamilola FayanjuPhiladelphia$668K
- Maher El ChaarAllentown$667K
- George EidPittsburgh$623K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.